本文转自http://pathology21.sysucc.org.cn/ContereIndex.aspx?id=9

第五届安德森癌症中心与中国姊妹医院病理论坛

                           21世纪病理学论坛（P21）-从分子诊断到癌症个体化治疗

由中山大学肿瘤防治中心和美国德克萨斯大学M.D.安德森癌症中心联合主办的21世纪病理学论坛（P21）-从分子诊断到癌症个体化治疗将于2013年5月31日-6月2日，在美丽的羊城-广州隆重举行。

本届P21论坛关注肿瘤病理学诊断和个体化治疗的最新进展，包括分子诊断病理学进展、新技术应用和新的肿瘤分类系统等。大会将涉及妇科肿瘤、胶质瘤、甲状腺肿瘤、恶性黑色素瘤、神经内分泌肿瘤、结直肠癌、软组织肿瘤和前列腺癌等一系列肿瘤性疾病。会议将重点介绍肿瘤病理学诊断中的分子病理检测及其在肿瘤个体化治疗中的应用、病理学诊断与分类中的最新进展、免疫组化技术在肿瘤病理诊断中的应用与新策略、以及21世纪病理医生培养等重要问题。

本次大会邀请了13位来自美国M.D.安德森癌症中心和多位来自国内的著名病理学家作专题讲座并进行病例讨论等学术交流。大会设全程英文翻译。所有参会人员均可获得国家级（Ⅰ类）继续教育学分7分。

我们热情地欢迎您在美丽的春夏之交来广州参会！

                                                                                                                                   21世纪病理学论坛组委会

                                                                            执行主席：云径平   邵建永

Sun Yat-sen University Cancer Center and The University of Texas MD Anderson Cancer Center5^th Biennial Pathology Symposium of M. D. Anderson Cancer Center - Chinese Sister Institutions  Pathology of the 21st Century: From Molecular Diagnostics to Personalized Cancer Therapy  

Program Directors: Jingping Yun, Jianyong Shao, Aysequl Sahin, Dongfeng Tan, and Jinsong Liu

Organizing Committee: Bogdan Czeriniak, Michael Deavers, Greg Fuller, Jinsong Liu, TJ, Liu, Aysequl Sahin, Jianyong Shao, Dongfeng Tan, Dan Xie, and Jingping Yun

Dear Colleagues,

We are pleased to invite you to Pathology of the 21st Century: From Molecular Diagnostics to Personalized Cancer Therapy, which will be held from May 31 to June 2, 2013, in Guangzhou, China. This symposium is jointly sponsored and organized by Sun Yat-sen University Cancer Center and The University of Texas MD Anderson Cancer Center.

The Biennial Pathology Symposium of M. D. Anderson Cancer Center-Chinese Sister Institutions was first held in partnership with MD Anderson’s sister institute, Fudan University Shanghai Cancer Center in Shanghai in 2005. Pathology of the 21st Century (P21) is an international program at MD Anderson that has been held six times, in the United States and elsewhere. P21 emphasizes the use of innovative diagnostic tools for neoplastic disorders and new neoplastic entities and classification systems. As one of MD Anderson’s sister institutes in China, Sun Yat-sen University Cancer Center is honored to host this year’s combined biennial pathology symposium and P21 conference in China.

The main theme of this conference is novel approaches to the pathological diagnosis and classification of tumors. The conference topics will cover a wide spectrum of neoplastic diseases, such as gynecological tumors, gliomas, thyroid neoplasia, melanocytic lesions, neuroendocrine tumors, colorectal cancer, and prostate cancer. Particular attention will be given to molecular and cytogenetic testing in pathological diagnosis and personalized therapy. Relevant topics, such as the application of and approach to immunohistochemical analyses in tumor pathology and the training of pathologists in the 21st century, will also be presented.

Professor Yi-Xin Zeng, president of Sun Yat-sen University Cancer Center, and Professor Ronald A. DePinho, president of MD Anderson, will be the chairpersons of this meeting. Thirteen leading pathologists from MD Anderson and several renowned Chinese pathologists will present lectures and interact with attendees. This conference will offer a great platform for exploring the development of pathology in the 21st century. 

We look forward to your participation and hope you enjoy your time in Guangzhou. 

Prof. Jing-Ping Yun                                                         Prof. Jian-Yong Shao

Director, Department of Pathology        Director, Department of Molecular Diagnostics

Agenda/会议日程

 Friday, May 31,  2013   (2013年5月31日, 周五)

10am to 5pm            Registration in Huatai Hotel 

                                  上午10点-下午5点 注册 (华泰宾馆)

Saturday, June 1, 2013  (2013年6月1日, 周六)

Sunday, June 2, 2013  (2013年6月2日, 周日)

Moderators: Charles Guo and Jing-ping Yun